In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors

Radiotherapy and Oncology

Volumn 67, Issue 1, 2003, Pages 53-61

  Mahy, Pierre ^a   De Bast, Marc ^a   Gallez, Bernard ^a   Gueulette, John ^a   Koch, Cameron J ^b   Scalliet, Pierre ^a   Grégoire, Vincent ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

2 2 nitro 1H imidazol 1yl N (2,2,3,3,3 pentafluoropropyl) acetamide; Electron paramagnetic resonance; Immunofluorescence; Nitroimidazole markers; Tumor hypoxia

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; CHARCOAL; MONOCLONAL ANTIBODY; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; CALIBRATION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTRON SPIN RESONANCE; FIBROSARCOMA; FROZEN SECTION; IMMUNOFLUORESCENCE; MALE; MOUSE; NONHUMAN; OXIMETRY; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; SPECTROMETER; STATISTICAL SIGNIFICANCE; TUMOR MODEL; WILCOXON SIGNED RANKS TEST;

EID: 0038368763     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00028-8     Document Type: Article

References (50)

1. Bacic G., Liu K.J., O'Hara J.A., et al. Oxygen tension in a murine tumor: a combined EPR and MRI study. Magn Reson Med. 30:1993;568-572.
2. Begg A.C., Janssen H., Sprong D., et al. Hypoxia and perfusion measurements in human tumors-initial experience with pimonidazole and IUdR. Acta Oncol. 40:2001;924-928.
3. Brizel D., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:1996;941-943.
4. Busch T.M., Hahn S.M., Evans S.M., Koch C.J. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]. Cancer Res. 60:2000;2636-2642.
5. 18F]-EF5, a marker for PET detection of hypoxia: synthesis of a precursor and a new fluorination procedure. Appl Radiat Isot. 54:2001;73-80.
6. Evans S.M., Joiner B., Jenkins W.T., Laughlin K.M., Lord E.M., Koch C.J. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]. Br J Cancer. 72:1995;875-882.
7. Evans S.M., Jenkins W.T., Joiner B., Lord E.M., Koch C.J. 2-Nitromidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors. Cancer Res. 56:1996;405-411.
8. Evans S.M., Koch C.J., Laughlin K.M., Jenkins W.T., van Winkle T., Wilson D.F. Tamoxifen induces Hypoxia in MCF-7 xenografts. Cancer Res. 57:1997;5155-5161.
9. Evans S.M., Hahn S., Pook D.R., et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 60:2000;2018-2024.
10. 18F]EF1. Nucl Med. 41:2000;327-336.
11. Evans S.M., Hahn S.M., Magarelli D.P., et al. Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys. 49:2001;587-596.
12. Gallez B., Jordan B.F., Baudelet C., Misson P.D. Pharmacological modifications of the partial pressure of oxygen in tumors: evaluation using in vivo EPR oximetry. Magn Reson Med. 42:1999;627-630.
13. Gatenby R.A., Kessler H.B., Rosenblaum J.S., et al. Oxygen distribution in squamous cell carcinoma mestastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 14:1988;831-838.
14. Goda F., Bacic G., O'Hara J.A., Gallez B., Swartz H.M., Dunn J.F. The relationship between partial pressure of oxygen and perfusion in two murine tumors after X-Ray irradiation: a combined gadopentetate dimeglumine dynamic magnetic resonance imaging and in vivo electron paramagnetic resonance oximetry study. Cancer Res. 56:1996;3344-3349.
15. Gross M.W., Karbach U., Groebe K., Franko A.J., Mueller-Klieser W. Calibration of misonidazole labeling by simultaneous measurements of oxygen tension and labeling density in multicellular spheroids. Int J Cancer. 61:1995;567-573.
16. Hall E.J. The oxygen effect and reoxygenation. Hall E.J. Radiobiology for the radiologists. 1994;133-152 J. B. Lippincott Company, Philadelphia.
17. Hockel M., Schlenger K., Aral B., Mitze M., Schaffer U., Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
18. Hockel M., Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 93:2001;266-276.
19. Hodgkiss R.J., Jones G., Long A., et al. Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Br J Cancer. 63:1991;119-125.
20. Jenkins W.T., Evans S.M., Koch C.J. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and Eppendorf needle electrode. Int J Radiat Oncol Biol Phys. 46:2000;1005-1017.
21. Jordan B.F., Baudelet C., Gallez B. Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals. MAGMA. 7:1998;121-129.
22. 18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. Bioorg Med Chem. 9:2001;665-675.
23. Kaanders J.H.A.M., Wijffels K.I.E.M., Marres H.A.M., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res. 62:2002;7066-7074.
24. Kachur A.V., Dolbier W.R., Evans S.M., et al. Synthesis of new hypoxia markers EF1 and [F-18]-EF. Appl Radiat Isotopes. 51:1999;643-650.
25. Kavanagh M.C., Tsang V., Chow S., et al. A comparison in individual murine tumors of techniques for measuring oxygen levels. Int J Radiat Oncol Biol Phys. 44:1999;1137-1146.
26. Kennedy A.S., Raleigh J.A., Perez G.M., et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Phys. 37:1997;897-905.
27. Koch C.J., Evans S.M., Lord E.M. Oxygen dependance of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs. bound radioactivity. Br J Cancer. 72:1995;869-874.
28. Koch C.J., Hahn S.M., Rockwell K. Jr, Covey J.M., McKenna W.G., Evans S.M. Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles. Cancer Chemother Pharmacol. 48:2001;177-187.
29. Laughlin K.M., Evans S.M., Jenkins W.T., et al. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. J Pharmacol Exp Ther. 277:1996;1049-1057.
30. Lee J., Siemann D.W., Koch C.J., Lord E.M. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int J Cancer. 67:1996;372-378.
31. Lord E.M., Harwell L., Koch C.J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res. 53:1993;5271-5276.
32. Mader K., Gallez B., Swartz H.M. In vivo EPR: an effective new tool for studying pathophysiology, physiology and pharmacology. Appl Radiat Isot. 47:1996;1663-1667.
33. Mason R.P., Antich P.P., Babcock E.E., Constantinescu A., Peschke P., Hahn E.W. Non-invasive determination of tumor oxygen tension and local variation with growth. Int J Radiat Oncol Biol Phys. 29:1994;95-103.
34. Maxwell P.H., Dachs G.U., Gleadle J.M., et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA. 94:1997;8104-8109.
35. Milas L., Hunter N., Mason K., Withers H.R. Immunological resistance to pulmonary metastases in C3Hf/Bu mice bearing syngeneic fibrosarcoma of different sizes. Cancer Res. 34:1974;61-71.
36. Milas L., Wike J., Hunter N., Volpe J., Basic I. Macrophage content of murine sarcomas and carcinomas: association with tumor growth parameters and tumor radiocurability. Cancer Res. 47:1987;1069-1075.
37. Nilges M.J., Walczak T., Swartz H.M. One GHz in vivo ESR spectrometer operating with a surface probe. Phys Med. 2:1989;195-201.
38. 2 measurements by electron paramagnetic resonance oximetry. Radiat Res. 150:1998;549-556.
39. Olive P.L., Luo C.M., Banath J.P. Local hypoxia is produced at sites of intratumour injection. Br J Cancer. 86:2002;429-435.
40. Raleigh J.A., Koch C.J. The importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem Pharmacol. 40:1990;2457-2464.
41. Raleigh J.A., Dewhirst M.W., Thrall D.E. Measuring tumor hypoxia. Sem Radiat Oncol. 6:1996;37-40.
42. Raleigh J.A., Chou S.G., Arteel G.E., Horsman M.R. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 151:1999;580-589.
43. 18F]Fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 36:1996;417-428.
44. Rofstad E.K., Halsor E.F. Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. Br J Cancer. 86:2002;301-308.
45. Stone H.B., Brown J.M., Phillips T.L., Sutherland R.M. Oxygen in human tumors: correlations between methods of measurements and response to therapy. Radiat Res. 136:1993;422-434.
46. 2? Adv Exp Med Biol. 428:1997;663-670.
47. Tannock I.F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer. 22:1968;258-273.
48. Thomlison R.H., Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 9:1955;539-549.
49. Woods M.L., Koch C.J., Lord E.M. Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5, and monoclonal antibodies. Int J Radiat Oncol Biol Phys. 34:1996;93-101.
50. Young S.D., Hill R.P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J Natl Cancer Inst. 82:1990;371-380.